D30 - Shift from Reactive to Proactive in Diabetes Care Through Generative AI

Sunday, August 10, 2025

3:30 PM – 4:15 PM MT

CE/CME Hours: .75 CE

Pharmacology Hours: 0.0 CE

Primary Presenter(s)

Clipper Young, PharmD, MPH, CDE, BC-ADM, BCGP, APh, FADCES (he/him/his)

Associate Professor and Clinical Pharmacist
Touro University California
Fairfield, California

Disclosure(s): Sanofi: Consultant / Advisory Board (Terminated, October 31, 2024)

Co-Presenter(s)

Janice MacLeod, MA, RD, CDCES, FADCES

Diabetes-Cardiometabolic Consultant
Janice MacLeod Consulting
Glen Burnie, Maryland

Disclosure(s): Welldoc: Consultant / Advisory Board (Ongoing)

This session will equip attendees with foundational artificial intelligence (AI) literacy to understand what AI is, how generative AI works, and its potential to shift diabetes care from reactive (downstream) to proactive (upstream). Participants will explore practical applications of generative AI in their clinical workflows, including integrating tools for personalized patient care, streamlining documentation, and enhancing decision-making. The presenters also address leveraging AI at individual and clinic/system levels, empowering attendees to lead innovation in their practice settings.

Disclosure(s):

Clipper Young, PharmD, MPH, CDE, BC-ADM, BCGP, APh, FADCES: Sanofi: Consultant / Advisory Board (Terminated, October 31, 2024)

Janice MacLeod, MA, RD, CDCES, FADCES: Welldoc: Consultant / Advisory Board (Ongoing)